Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

KARAMALI A BANDEALY

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1982686135
CMS profile
181148
Location
KISSIMMEE, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$1,872.08

94 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,864.26 93
Education $7.82 1

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 2; records 51–94 of 94 matching records. This page contains 44 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

KARAMALI A BANDEALY

NPI 1982686135 · CMS profile ID 181148

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

KISSIMMEE, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–94 of 94 matching records. This page contains 44 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1982686135?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
KARAMALI A BANDEALY, NPI 1982686135, CMS profile ID 181148. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–94 of 94 matching records. This page contains 44 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1982686135?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). KARAMALI A BANDEALY, NPI 1982686135, CMS profile ID 181148. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–94 of 94 matching records. This page contains 44 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1982686135?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
KARAMALI A BANDEALY, NPI 1982686135, CMS profile ID 181148, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–94 of 94 matching records. This page contains 44 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1982686135?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

94 matching records · $1,872.08 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 94 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–94 of 94.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $17.7205/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812599295 CMS
Janssen Biotech, Inc. $19.6005/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788891229 CMS
E.R. Squibb & Sons, L.L.C. $13.9005/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783560969 CMS
Amgen Inc. $20.6905/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826534005 CMS
AbbVie Inc. $14.4704/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 793977111 CMS
Horizon Therapeutics plc $15.6104/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797072133 CMS
Amgen Inc. $22.6404/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825492267 CMS
Janssen Biotech, Inc. $16.1504/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788891233 CMS
AbbVie Inc. $22.1004/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 793977107 CMS
Horizon Therapeutics plc $7.8204/20/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797072127 CMS
PFIZER INC. $28.6404/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832623777 CMS
Amgen Inc. $13.4904/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825492213 CMS
Lilly USA, LLC $30.8804/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818628401 CMS
AbbVie Inc. $24.7204/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 793977103 CMS
Lilly USA, LLC $0.8104/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818617033 CMS
Lilly USA, LLC $22.2404/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818643733 CMS
Novartis Pharmaceuticals Corporation $23.8204/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812599293 CMS
AbbVie Inc. $21.2603/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 793977099 CMS
E.R. Squibb & Sons, L.L.C. $7.3703/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783560959 CMS
UCB, Inc. $17.6403/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807327743 CMS
Amgen Inc. $19.8603/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825492207 CMS
Janssen Biotech, Inc. $23.8503/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788891221 CMS
E.R. Squibb & Sons, L.L.C. $24.3803/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783560953 CMS
Horizon Therapeutics plc $19.5403/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797072123 CMS
Amgen Inc. $6.6003/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825492249 CMS
AbbVie Inc. $16.5903/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 793977095 CMS
Amgen Inc. $22.7202/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825492201 CMS
Amgen Inc. $18.0602/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825492243 CMS
Horizon Therapeutics plc $11.7002/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797072119 CMS
AbbVie Inc. $28.8002/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 793977091 CMS
Horizon Therapeutics plc $14.3302/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797072115 CMS
PFIZER INC. $20.8402/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832663315 CMS
Horizon Therapeutics plc $12.1802/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797072111 CMS
AbbVie Inc. $18.2702/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 793977087 CMS
E.R. Squibb & Sons, L.L.C. $11.2702/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783560935 CMS
Novartis Pharmaceuticals Corporation $7.1102/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812599291 CMS
AbbVie Inc. $27.8301/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 793977083 CMS
GlaxoSmithKline, LLC. $19.7701/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801647251 CMS
Amgen Inc. $27.7001/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825492237 CMS
E.R. Squibb & Sons, L.L.C. $22.2101/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783560933 CMS
Janssen Biotech, Inc. $11.7401/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788891231 CMS
Amgen Inc. $4.5001/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825492231 CMS
Novartis Pharmaceuticals Corporation $13.7101/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812599289 CMS
AbbVie Inc. $19.7401/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 793977079 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,047.53 63
PY2020 $1,154.02 71
PY2021 $1,872.08 94
PY2022 $1,795.87 102
PY2023 $777.82 42
PY2025 $32.56 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $221,043.99 23
PY2024 Recipient $104.58 1
PY2024 Principal investigator $127,262.55 42
PY2023 Principal investigator $116,400.97 52
PY2022 Principal investigator $181,117.23 93
PY2021 Principal investigator $20,099.57 35
PY2019 Principal investigator $14,164.28 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

23 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $4,424.62 12/08/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246435580
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $7,889.56 11/19/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435541
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $7,688.59 11/07/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246435575
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $8.45 09/17/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435608
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $222.74 09/03/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435604
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $1,802.25 08/06/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246435558
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $1,258.18 07/23/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435527
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $3,911.62 07/11/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246435567
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $4,166.89 06/25/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435532
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $5,495.51 06/11/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246435562
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $558.29 06/09/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246435600
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $232.56 06/04/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435596
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $3,549.77 04/23/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435588
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $1,258.18 04/02/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435584
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $116.28 03/26/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435592
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $2,019.94 03/17/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246435571
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $2,783.02 03/14/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246435536
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $2,526.52 03/10/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246435545
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $4,166.89 03/03/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435548
Principal investigator 1 Eli Lilly and Company $1,963.50 02/25/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH
EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH ACTIVE PSORIATIC ARTHRITIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSA) No dispute reported 06/30/2026 1187892662
Principal investigator 1 Eli Lilly and Company $124,428.00 02/10/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH
EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH ACTIVE PSORIATIC ARTHRITIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSA) No dispute reported 06/30/2026 1187892664
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $11,253.94 02/05/2025 Non-covered Recipient Entity
VIDA CLINICAL RESEARCH LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246435553
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $29,318.69 01/06/2025 Non-covered Recipient Entity
Vida Clinical Research
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) No dispute reported 06/30/2026 1235991961